Home » Stocks » Novan

Novan, Inc. (NOVN)

Stock Price: $0.651 USD 0.013 (1.96%)
Updated Aug 6, 2020 11:52 AM EDT - Market open

Stock Price Chart

Key Info

Market Cap 114.55M
Revenue (ttm) 5.01M
Net Income (ttm) -29.52M
Shares Out 128.22M
EPS (ttm) -1.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 6, 2020
Last Price $0.651
Previous Close $0.638
Change ($) 0.013
Change (%) 1.96%
Day's Open 0.640
Day's Range 0.624 - 0.658
Day's Volume 4,881,702
52-Week Range 0.215 - 3.720

More Stats

Market Cap 114.55M
Enterprise Value 98.34M
Earnings Date (est) Nov 17, 2020
Ex-Dividend Date n/a
Shares Outstanding 128.22M
Float 59.21M
EPS (basic) -1.06
EPS (diluted) -1.04
FCF / Share -0.70
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 3.00M
Short Ratio 0.09
Short % of Float 3.54%
Beta -0.26
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 22.87
PB Ratio n/a
Revenue 5.01M
Operating Income -30.18M
Net Income -29.52M
Free Cash Flow -25.95M
Net Cash 16.21M
Net Cash / Share 0.09
Gross Margin -100.22%
Operating Margin -602.46%
Profit Margin -589.30%
FCF Margin -517.99%
ROA -65.77%
ROE n/a
ROIC -519.50%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (1)

Buy 1
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$1.50*
Low
1.50
Current: $0.651
High
1.50
Target: 1.50
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year201920182017201620152014
Revenue4.905.992.65--0.11
Revenue Growth-18.28%126.42%----
Gross Profit4.905.992.65--0.11
Operating Income-30.69-28.56-35.68-59.83-25.83-11.83
Net Income-30.38-29.24-36.62-59.70-28.06-11.39
Shares Outstanding26.2525.8015.985.992.272.20
Earnings Per Share-1.16-1.13-2.29-9.97-12.37-5.17
Operating Cash Flow-19.88-28.63-29.86-49.17-22.19-8.60
Capital Expenditures-0.42-1.06-2.14-6.22-1.21-0.77
Free Cash Flow-20.30-29.68-32.00-55.39-23.40-9.38
Cash & Equivalents14.258.733.0635.1546.237.42
Total Debt6.268.028.038.040.010.02
Net Cash / Debt7.990.71-4.9727.1146.227.40
Assets29.1026.3621.1352.4749.829.93
Liabilities51.3819.9222.8521.415.101.78
Book Value-22.286.44-1.7231.07-60.08-29.55
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Novan, Inc.
Country United States
Employees 28
CEO Paula Brown Stafford

Stock Information

Ticker Symbol NOVN
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: NOVN
IPO Date September 21, 2016

Description

Novan, Inc., a clinical development-stage biotechnology company, focuses on the development and commercialization of nitric oxide-based therapies to treat dermatological and oncovirus-mediated diseases. Its clinical stage dermatology product candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-spectrum anti-fungal gel for the treatment of fungal infections of the skin and nails, including athlete's foot and fungal nail infections; and SB414, a topical cream-based product candidate for the treatment of inflammatory skin diseases. The company also develops SB207, a topical anti-viral product candidate. Novan, Inc. has a license agreement with Sato Pharmaceutical Co., Ltd.; and a strategic alliance with Orion Corporation. The company was founded in 2006 and is headquartered in Morrisville, North Carolina.